TRIB1 regulates LDL metabolism through CEBPα-mediated effects on the LDL receptor in hepatocytes

Genetic variants near the TRIB1 gene are highly significantly associated with plasma lipid traits and coronary artery disease. While TRIB1 is likely causal of these associations, the molecular mechanisms are not well understood. Here we sought to investigate how TRIB1 influences low density lipoprotein cholesterol (LDL-C) levels in mice. Hepatocyte-specific deletion of Trib1(Trib1(Delta)hep) in mice increased plasma cholesterol and apoB and slowed the catabolism of LDL-apoB due to decreased levels of LDL receptor (LDLR) mRNA and protein. Simultaneous deletion of the transcription factor CCAAT/enhancer-binding protein alpha (CEBP alpha) with TRIB1 eliminated the effects of TRIB1 on hepatic LDLR regulation and LDL catabolism. Using RNA-seq, we found that activating transcription factor 3 (Atf3) was highly upregulated in the livers of Trib1(Delta)hep but not Trib1(Delta)hep Cebpa(Delta)hep mice. ATF3 has been shown to directly bind to the CEBP alpha protein, and to repress the expression of LDLR by binding its promoter. Blunting the increase of ATF3 in Trib1(Delta)hep mice reduced the levels of plasma cholesterol and partially attenuated the effects on LDLR. Based on these data, we conclude that deletion of Trib1 leads to a posttranslational increase in CEBP alpha, which increases ATF3 levels, thereby contributing to the downregulation of LDLR and increased plasma LDL-C.

Automated summary

The study identified that the TRIB1 gene influences LDLR regulation and LDL catabolism in mice, involving multiple molecular mechanisms such as CEBPα and ATF3.